Document is current
Any future updates will be listed below
-
Authors
Krossa, Sebastian https://orcid.org/0000-0002-1959-0130
Andersen, Maria K. https://orcid.org/0000-0003-2883-2450
Sandholm, Elise M.
Wess, Maximilian https://orcid.org/0009-0002-4227-6569
Kiviaho, Antti https://orcid.org/0000-0001-7419-0773
Sharma, Abhibhav https://orcid.org/0000-0001-5513-6210
Hakkola, Sini
Hao, Yangyang
Alshalalfa, Mohammed
Davicioni, Elai
Viset, Trond
Størkersen, Øystein
Karnes, R. Jeffrey
Spratt, Daniel E. https://orcid.org/0000-0002-5973-4741
Giskeødegård, Guro F. https://orcid.org/0000-0003-2157-8824
Nykter, Matti https://orcid.org/0000-0001-6956-2843
Rye, Morten B.
Urbanucci, Alfonso
Tessem, May-Britt https://orcid.org/0000-0001-5734-2157
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (755306)
Kreftforeningen (208263-2019)
grants received from Liaison Committee between the Central Norway Regional Health Authority (RHA) and NTNU and Terje Eugen Johnsen funds, Norway
- License Information
-
More Information
Article History
Received: 16 July 2024
Accepted: 3 October 2025
First Online: 19 November 2025
Competing interests
: M.A. and E.D. are employees and Y.H. is a former employee of Veracyte, Inc (San Diego, CA) who make the Decipher prostate genomic classifier test and own the GRID software/database. The authors declare no further competing interests.
